Tristel
Healthcare Medical Imaging

Business Overview

Tristel is a manufacturer of infection control, contamination control and hygiene products. It has three principal activities:

– Hospital infection prevention and control under the Tristel brand

– Contamination control in the pharmaceutical and personal care industry under the Crystel brand

– Animal health infection prevention and control under the Anistel brand

The Tristel story began in 1993 when the founding shareholders developed a proprietary chlorine dioxide formulation to be used for the disinfection of flexible endoscopes to replace glutaraldehyde. Glutaraldehyde was at the time used universally throughout all hospitals in the United Kingdom, and indeed worldwide, for the disinfection of heat-sensitive medical instruments. However, it was known to be toxic.

During the course of the following decade Tristel gradually captured significant market share in the United Kingdom hospital market. In June 2005 Tristel plc was listed on the London Stock Exchange AIM market.

By this time the Company had developed a broader vision for the use of its chlorine dioxide chemistry and had set in train its strategy to apply the chemistry to the four vectors of transmission of infection in a hospital: instruments, surfaces, water and skin.

A key milestone in the development of the Tristel group was the establishment of its manufacturing plant in Cambridgeshire in 2007.

Having established its capability as an ISO 9001:2008 and BS EN 13485:2003 manufacturer of high-level disinfectants, in 2009 Tristel acquired the intellectual property and manufacturing rights for a portfolio of disinfectants used in animal healthcare facilities worldwide. Tristel manufactured these products until March 2012 when it created its Anistel brand and has since served the animal healthcare market directly.

Tristel now has established subsidiaries and associated companies in New Zealand, Hong Kong, China, Italy and branch operations in Germany and Russia.

Founded
1998
Investor type
Company
Business model preference
B2B
Series preference
Series B, Series C
Offering preference
Hardware, Software
AI type preference
Computer Vision
Sectors
Healthcare Medical Imaging

Investment Portfolio

Startup

Operating Status

Offering Type

Business Model

Total Funding

AI Employees

MobileODT
Active
Hardware, Software
B2B
$19.3 M
4

Investment Rounds History

Startup

Date Announced

Funding Round

Amount Raised

Investors

$4M

View All Investors (4 Total)
View All Investors (2 Total)

Similar Investors

Intel Capital
TYPE
Corporate Venture Capital
Gefen Capital
TYPE
Venture Capital
Lightspeed Venture Partners
TYPE
Venture Capital
Primary Venture Partners
TYPE
Venture Capital
MIN CHEQUE
$0.5 M
Tristel
TYPE
Company
Qure Ventures
TYPE
Venture Capital
MIN CHEQUE
$0.5 M
Emery Capital
TYPE
Venture Capital
Qualcomm Ventures
TYPE
Corporate Venture Capital
Max Ventures
TYPE
Venture Capital
Bloomberg Beta
TYPE
Corporate Venture Capital
MIN CHEQUE
$0.025 M
SeedIL Ventures
TYPE
Venture Capital
Jerusalem Venture Partners
TYPE
Venture Capital
Viola Ventures
TYPE
Venture Capital
MIN CHEQUE
$1 M
Horizon 2020
TYPE
Government
Terra Venture Partners
TYPE
Venture Capital
Union Tech Ventures
TYPE
Corporate Venture Capital
7wire Ventures
TYPE
Venture Capital
Tara Health
TYPE
Foundation
Mangrove Capital Partners
TYPE
Venture Capital
Pitango Venture Capital
TYPE
Venture Capital

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events